Inflammatory Bowel Disease – Crohn’s Disease & Ulcerative Colitis

Evidence-based treatment & prevention

Inflammatory bowel disease (IBD) has become a Western epidemic since the beginning of the 21st century and has also been on the rise for a few years in emerging countries with increasingly Western lifestyles. However, there are still significant, geographic differences in the incidences, especially compared to rural populations and indigenous tribes. What risk factors do promote the epidemic of inflammatory bowel disease and what is actually effective to prevent chronic inflammation and even treat it, without side effects?

Patients with inflammatory bowel disease can be in remission in more than 90% of the cases even after 3 years, given the right diet - no drug has been able to show comparable results.

IBD is not curable and is a major burden for affected people and for national healthcare systems. It is therefore of utmost importance to provide science based information about the risk factors and how to prevent these conditions.


What factors trigger an inflammatory episode in ulcerative colitis and Crohn’s disease? How can a patient be kept in remission for as long as possible and spared the next painful relapse – ideally with as little medication as possible?


The current medication approach produces an average relapse rate of 16% – 41% in sufferers after just 1 year (16%: medication taken regularly. 41%: non-adherent patients) – not to mention medication-related side effects, reduced quality of life and the incredible costs for patients and the healthcare system. In contrast,an evidence-based strategy that can keep > 90% of patients in remission even after 3 years WITHOUT medication is a dietary approach. 


Nutrition plays a completely underestimated and subordinate role in medical guidelines so far, but the evidence even for therapeutic purposes is available 

The current state of evidence on therapeutic interventions & prevention.


Request Dr. Schwitalla

as speaker

Request as a consultant